Investing

Abbott Laboratories : ABT

ABT

Stock Data

$89.46

$1.33 (1.46%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Abbott Laboratories is a global healthcare company with a broad portfolio of products across various segments, including pharmaceuticals, diagnostics, nutritional products, and medical devices. Founded in 1888 and headquartered in North Chicago, Illinois, Abbott is known for its innovative solutions in managing health conditions such as diabetes, cardiovascular diseases, and chronic pain. It also offers a range of diagnostics equipment and tests for infectious diseases, including HIV and influenza, as well as nutritional products for both pediatric and adult patients. Abbott's commitment to improving lives is evident through its diverse offerings aimed at enhancing health and well-being worldwide.

All Abbott Laboratories Articles

311 Articles

Lee Jackson | Apr 22, 2026 at 7:58 AM EDT

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Abbott Laboratories, Airbnb, Biogen, Cava Group, GitLab, Halliburton, Qualcomm, Seagate, Toast, and More

Pre-Market Stock Futures: Futures are trading higher as we hit the midweek point. All major indices finished lower on Tuesday…

Trey Thoelcke | Apr 21, 2026 at 11:20 AM EDT

Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love

Boston Scientific (NYSE: BSX | BSX Price Prediction) trades around $61, with analyst price targets ranging from $69 (conservative) to…

Trey Thoelcke | Apr 20, 2026 at 7:05 AM EDT

Has the Abbott Laboratories Sell-Off Finally Created an Entry Point?

Whether Abbott Laboratories (NYSE: ABT | ABT Price Prediction) stock is at a good entry point depends on your investment…

Vandita Jadeja | Apr 17, 2026 at 7:49 AM EDT

Abbott Price Prediction: Where Will the Stock Be in 2027

Abbott Laboratories (NYSE: ABT | ABT Price Prediction) has pulled back sharply in 2026. Our Wall St. price target for…

Joel South | Mar 11, 2026 at 10:25 AM EDT

Intuitive Surgical Upgraded to Buy by Citi — Plus Key Moves on Stryker and Abbott

Citi is making a clear statement about the health of U.S. medical technology heading into the spring: the sector’s fundamentals…

Lee Jackson | Mar 11, 2026 at 8:10 AM EDT

Hope for the Best and Plan for the Worst: The 5 Safest Dividend Aristocrats

The stock market could face serious trouble in 2026 as extreme valuations collide with geopolitical tensions, AI investment skepticism, and…

Joel South | Feb 12, 2026 at 1:04 PM EST

Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next?

Abbott Laboratories just paid its quarterly dividend of $0.63 per share on February 13, 2026, marking a 6.8% increase from…

Lee Jackson | Feb 4, 2026 at 8:43 AM EST

5 Goldman Sachs Top Stock Picks Have Huge Upside Potential and Pay Dividends

These five Goldman Sachs Conviction List stock picks have significant upside relative to the assigned price target and come with…

Ian Cooper | Jan 30, 2026 at 6:18 AM EST

Stock Market Live January 30, 2026: S&P 500 (SPY) Deep in the Red

The pullback continues. After yesterday’s pullbacks and late-day recovery on the Dow, the major indices are getting walloped. At the…

Trey Thoelcke | Jan 27, 2026 at 8:45 AM EST

GameStop CEO Picks Up 1M Shares, and Other Insiders Return to the Buy Window

The CEO of GameStop just picked up a million shares, and insiders are returning for more shares of Under Armour,…

William Temple | Jan 15, 2026 at 11:55 AM EST

Dividend King Abbott Shows Why 52 Consecutive Increases Weren’t Luck With Strong Cash Flow Coverage

Abbott Laboratories (NYSE: ABT | ABT Price Prediction) doesn’t just pay dividends. It grows them. For 52 consecutive years. That’s…

David Beren | Jan 8, 2026 at 3:40 PM EST

The Dividend Aristocrats No One’s Talking About (And Their 30+ Year Track Records)

Dividend aristocrats get plenty of attention, but most of the time the spotlight falls on the big names like Johnson…

William Temple | Dec 8, 2025 at 8:21 AM EST

Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump

Abbott Laboratories (NYSE: ABT | ABT Price Prediction) and Eli Lilly (NYSE: LLY) just reported Q3 earnings that highlight two…

Lee Jackson | Nov 13, 2025 at 1:46 PM EST

Goldman Sachs Says US Stocks Could Lag for 10 Years: 5 Strong Buy Value Dividend Ideas

Here are five Goldman Sachs stock picks that conservative growth and income investors should consider moving to for what could…

Lee Jackson | Oct 26, 2025 at 12:25 PM EDT

Goldman Sachs Still Says Sell-Off Coming – 5 Safe Conviction List Picks

Founded in 1869, Goldman Sachs is the world’s second-largest investment bank by revenue and is ranked 55th on the Fortune…